NASDAQ: IRWDIronwood Pharmaceuticals Inc Stock Ownership - Who owns Ironwood Pharmaceuticals?
Insider buying vs selling
Have Ironwood Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ronald Silver | PFO PAO | 2026-07-07 | 127,890 | $4.52 | $578.06kSell |
| Julie McHugh | Director | 2026-06-16 | 21,571 | $3.73 | $80.46kSell |
| Alexander J. Denner | Director | 2026-03-17 | 6,725,000 | $3.05 | $20.51MSell |
| Alexander J. Denner | Director | 2026-03-17 | 5,800 | $3.31 | $19.20kSell |
| Thomas A. McCourt | Chief Executive Officer | 2026-02-24 | 103,526 | $3.66 | $378.91kSell |
| Tammi L. Gaskins | Chief Commercial Officer | 2026-02-24 | 11,239 | $3.66 | $41.13kSell |
| Gregory S. Martini | Chief Financial Officer | 2026-02-24 | 11,457 | $3.66 | $41.93kSell |
| Michael Shetzline | SVP CMO Head-ResDrug | 2026-02-24 | 17,012 | $3.66 | $62.26kSell |
| Ronald Silver | Principal Accounting Officer | 2026-02-24 | 12,621 | $3.66 | $46.19kSell |
| Minardo John | Chief Legal Officer | 2026-02-24 | 19,053 | $3.66 | $69.73kSell |
IRWD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IRWD insiders and whales buy or sell their stock.
IRWD Shareholders
What type of owners hold Ironwood Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bryan E. Roberts | 6.54% | 10,800,857 | $47.09M | Insider |
| Alexander J. Denner | 5.76% | 9,516,184 | $41.49M | Insider |
| Fmr LLC | 5.54% | 9,153,685 | $39.91M | Insider |
| Associates Venrock | 5.29% | 8,733,763 | $38.08M | Insider |
| Ridgeback Capital Investments LP | 4.14% | 6,842,839 | $29.83M | Insider |
| Peter M. Hecht | 1.35% | 2,236,766 | $9.75M | Insider |
| Thomas A. McCourt | 1.15% | 1,898,838 | $8.28M | Insider |
| Gina Bornino Miller | 0.47% | 770,952 | $3.36M | Insider |
| Mark G. Currie | 0.41% | 676,900 | $2.95M | Insider |
| Michael Shetzline | 0.40% | 658,037 | $2.87M | Insider |
IRWD vs Pharmaceutical Stocks
Ironwood Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.